[Chronic heart failure: progress in diagnosis and treatment. Topics: II. Progress in diagnosis: 2. Biomarker]. 2012

Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
Cardiovascular Medicine, Toyosato Hospital, Japan.

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D020097 Natriuretic Peptide, Brain A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS. Brain Natriuretic Peptide,Nesiritide,B-Type Natriuretic Peptide,BNP Gene Product,BNP-32,Brain Natriuretic Peptide-32,Natrecor,Natriuretic Factor-32,Natriuretic Peptide Type-B,Type-B Natriuretic Peptide,Ventricular Natriuretic Peptide, B-type,BNP 32,Brain Natriuretic Peptide 32,Natriuretic Factor 32,Natriuretic Peptide Type B,Natriuretic Peptide, B-Type,Natriuretic Peptide, Type-B,Natriuretic Peptide-32, Brain,Peptide, Brain Natriuretic,Peptide-32, Brain Natriuretic,Type B Natriuretic Peptide,Ventricular Natriuretic Peptide, B type

Related Publications

Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Takayoshi Tsutamoto, and Naoto Wada, and Takaya Yamakawa, and Kunihiro Ibe, and Hiroshi Sakai, and Chiho Kawahara, and Minoru Horie
February 2012, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!